Why I hold BEAM therapeutics stock and my position plans in future
Автор: Benjamin Yang
Загружено: 2021-02-19
Просмотров: 7399
Описание:
🎦 summary ⌲ Not all CRISPR based gene editing companies are the same!!! As of Feb 2020, there are 2 generations where BEAM therapeutics engineered CRISPR-Cas is considered newer. Their version is superior to generation 1 CRISPR-Cas in several ways and this video seeks to explain how and why they are superior so that biotech stock pickers can be informed! I also make predictions about where this technology will go in the future, tune in to 🧐
⏰
00:00 Context of video
00:37 Reasons why BEAM therapeutics is superior gene editing method
05:36 I detail my plans for my BEAM stock holdings
06:31 Where I think gene editing can go in the future, increasing company growth
Subscribe ⌲ https://www.youtube.com/c/BenjaminYan...
🖥 ⌲ https://byang.info
Disclosure ⌲ BYang is long (and own) BEAM stock
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
![Building my own Biotech portfolio [2021 guide]](https://imager.clipsaver.ru/pZxpjulEY_Q/max.jpg)
